These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8052424)

  • 1. How tight must blood glucose control be to prevent diabetic nephropathy?
    Hanssen KF
    Nephrol Dial Transplant; 1994; 9(3):226-7. PubMed ID: 8052424
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose control and renal and retinal complications of diabetes mellitus.
    JAMA; 1990 Aug; 264(5):573-4. PubMed ID: 2366295
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Whaley-Connell A; Sowers JR
    Diabetes; 2014 Jan; 63(1):45-7. PubMed ID: 24357694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 5. Educational guidelines for achieving tight control and minimizing complications of type 1 diabetes.
    Havas S
    Am Fam Physician; 1999 Nov; 60(7):1985-92, 1997-8. PubMed ID: 10569502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulating blood pressure and energy metabolism... vital for prognosis of diabetic patients].
    MMW Fortschr Med; 2000 Jan; 142(3):35-6. PubMed ID: 10726458
    [No Abstract]   [Full Text] [Related]  

  • 7. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 9. Tight glycemic control? Negative.
    Raskin P
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():21-4; discussion 24-5. PubMed ID: 1347535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood glucose control.
    Uchino H; Kawamori R
    Contrib Nephrol; 2001; (134):106-12. PubMed ID: 11665280
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there sustained renal benefit from previous intensive insulin therapy in people with type 1 diabetes?
    Shumak SL
    CMAJ; 2004 Jan; 170(1):40-1. PubMed ID: 14707216
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is it necessary to call into question the benefits of glycemic control in type-2 diabetes?].
    Scheen AJ
    Rev Med Suisse; 2014 Aug; 10(439):1531-2. PubMed ID: 25272668
    [No Abstract]   [Full Text] [Related]  

  • 15. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients.
    Barbosa J; Steffes MW; Sutherland DE; Connett JE; Rao KV; Mauer SM
    JAMA; 1994 Aug 24-31; 272(8):600-6. PubMed ID: 8057515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy.
    Kawamori R; Kamado K; Kamada T
    J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of Alpinia galanga in STZ induced diabetic nephropathy.
    Kaushik P; Kaushik D; Yadav J; Pahwa P
    Pak J Biol Sci; 2013 Aug; 16(16):804-11. PubMed ID: 24498833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
    Nathan DM; McGee P; Steffes MW; Lachin JM;
    Diabetes; 2014 Jan; 63(1):282-90. PubMed ID: 23990364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.